<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Though not obvious at a first glance, <z:hpo ids='HP_0003198'>myopathies</z:hpo> may be associated with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002401'>Stroke-like episodes</z:hpo> resemble <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> only to some extent but are a unique feature of certain <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorders with a pathogenesis at variance from that of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Only limited data are available about <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in pri-mary <z:hpo ids='HP_0003198'>myopathies</z:hpo> and the management of <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo> in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorders </plain></SENT>
<SENT sid="3" pm="."><plain>This review aims to summarize and discuss current knowledge about <z:hpo ids='HP_0001297'>stroke</z:hpo> in <z:hpo ids='HP_0003198'>myopathies</z:hpo> and to delineate <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo> from <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Literature review via PubMED using the search terms "<z:hpo ids='HP_0001297'>stroke</z:hpo>", "cerebrovascular", "ischemic event", "<z:hpo ids='HP_0001297'>stroke</z:hpo>-like episode", "<z:hpo ids='HP_0001297'>stroke</z:hpo>-mimic", "<z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorder" </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:hpo ids='HP_0001297'>Stroke</z:hpo> in <z:hpo ids='HP_0003198'>myopathies</z:hpo> is most frequently cardioembolic due to <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> or <z:hpo ids='HP_0004749'>atrial flutter</z:hpo>, dilated cardio-<z:hpo ids='HP_0003198'>myopathy</z:hpo>, or left-ventricular hypertrabeculation (noncompaction) </plain></SENT>
<SENT sid="6" pm="."><plain>The second most frequent cause of <z:hpo ids='HP_0001297'>stroke</z:hpo> in <z:hpo ids='HP_0003198'>myopathies</z:hpo> is <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathy</z:e> from <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> or <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, which may be a feature of <z:hpo ids='HP_0009071'>inflammatory myopathies</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Athero-<z:mp ids='MP_0000612'>sclerosis</z:mp> may either result from classical risk factors, such as <z:mp ids='MP_0002055'>diabetes</z:mp>, arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, hyperlpidemia, or smoking, associated with muscle disease, or may be an inherent feature of a <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorder </plain></SENT>
<SENT sid="8" pm="."><plain>In case of severe <z:hpo ids='HP_0001635'>heart failure</z:hpo> from <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> as a manifestation of muscle disease low flow <z:mpath ids='MPATH_124'>infarcts</z:mpath> may occur </plain></SENT>
<SENT sid="9" pm="."><plain>Thrombophilic <z:hpo ids='HP_0001297'>stroke</z:hpo> has been described in <z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e> and <z:e sem="disease" ids="C0011633" disease_type="Disease or Syndrome" abbrv="">dermatomyositis</z:e> in association with anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0002401'>Stroke-like episodes</z:hpo> occur particularly in <z:hpo ids='HP_0006789'>mitochondrial encephalopathy</z:hpo>, <z:e sem="disease" ids="C0001125" disease_type="Disease or Syndrome" abbrv="">lactacidosis</z:e> and <z:hpo ids='HP_0001297'>stroke</z:hpo>-likeepisode syndrome but rarely also in <z:e sem="disease" ids="C0023264" disease_type="Disease or Syndrome" abbrv="SNE">Leigh-syndrome</z:e> and other <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorders </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0002401'>Stroke-like episodes</z:hpo> are at variance from <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, pathogenically, clinically and on imaging </plain></SENT>
<SENT sid="12" pm="."><plain>They may be the manifestation of a vascular, metabolic or <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> process and present with predominantly vasogenic but also cytotoxic <z:hpo ids='HP_0000969'>edema</z:hpo> on MRI </plain></SENT>
<SENT sid="13" pm="."><plain>Differentiation between <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo> is essential in terms of management and prognosis </plain></SENT>
<SENT sid="14" pm="."><plain>Management of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in patients with <z:hpo ids='HP_0003198'>myopathy</z:hpo> is not at variance from the treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in non-myopathic patients </plain></SENT>
<SENT sid="15" pm="."><plain>There is no standardized treatment of <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo> but there is increasing evidence that these patients profit from the administration of <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> and conse-quent <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> treatment if associated with <z:hpo ids='HP_0001250'>seizure</z:hpo> activity </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> may be a complication of <z:hpo ids='HP_0003198'>myopathy</z:hpo> and needs to be delineated from <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo>, which are unique to <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorders, particularly <z:hpo ids='HP_0006789'>mitochondrial encephalopathy</z:hpo>, <z:e sem="disease" ids="C0001125" disease_type="Disease or Syndrome" abbrv="">lactacidosis</z:e> and <z:hpo ids='HP_0001297'>stroke</z:hpo>-likeepisode syndrome </plain></SENT>
<SENT sid="17" pm="."><plain><z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> in <z:hpo ids='HP_0003198'>myopathies</z:hpo> is most frequently cardioembolic and treatment is not at variance from non-myopathic <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="18" pm="."><plain>Treatment of <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo> is not standardized but seems to respond to <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> and adequate <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> treatment </plain></SENT>
</text></document>